HSCRP

Clinical trials for HSCRP explained in plain language.

Never miss a new study

Get alerted when new HSCRP trials appear

Sign up with your email to follow new studies for HSCRP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug aims to calm inflammation in kidney disease patients

Disease control Completed

This study tested a drug called TOUR006 in 143 adults with chronic kidney disease and high levels of a protein linked to inflammation (hs-CRP). The goal was to see if monthly or quarterly shots could safely lower inflammation. The study is complete, and results will show if the d…

Matched conditions: HSCRP

Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc., a Novartis Company • Aim: Disease control

Last updated Jun 15, 2026 18:54 UTC

HSCRP

Get alerted when new HSCRP trials appear

New drug aims to calm inflammation in kidney disease patients